Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction

Myocardial Metabolism in Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and now accounts for half of all heart failure cases. This rise is largely attributed to growing rates of obesity, hypertension, and diabetes. Despite its prevalence, the pathophysiological mechanisms of HFpEF are not f...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Henry, JA, Couch, LS, Rider, OJ
Natura:	Journal article
Lingua:	English
Pubblicazione:	MDPI 2024

Documenti analoghi

Intentional weight loss as a novel treatment for heart failure with preserved ejection fraction
di: Hundertmark, MJ, et al.
Pubblicazione: (2021)

Heart failure with preserved ejection fraction
di: Harper, A, et al.
Pubblicazione: (2018)

Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
di: Burrage, MK, et al.
Pubblicazione: (2021)

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
di: Xiao Wang, et al.
Pubblicazione: (2024-11-01)

The Role of Myocardial Ischemia in the Course of Heart Failure with Preserved Ejection Fraction in Patients with Cardiorenal Metabolic Syndrome
di: Yevhen Yu. Marushko, et al.
Pubblicazione: (2024-09-01)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
di: Jin Joo Park, et al.
Pubblicazione: (2022-10-01)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
di: Radu Tanacli, et al.
Pubblicazione: (2020-10-01)

Biomarkers in Heart Failure with Preserved Ejection Fraction
di: Antoni Bayes-Genis, et al.
Pubblicazione: (2022-06-01)

Treatment of heart failure with preserved ejection fraction
di: Alfredo Monteverde, et al.
Pubblicazione: (2018-06-01)

Heart failure with preserved ejection fraction – onset
di: Branimir Kanazirev
Pubblicazione: (2021-07-01)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
di: Roberta D'Assante, et al.
Pubblicazione: (2021-04-01)

Cardiac metabolism in patients with heart failure with mid-range ejection fraction
di: Hundertmark, M, et al.
Pubblicazione: (2018)

Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction
di: Leonardo Pioppi, et al.
Pubblicazione: (2023-09-01)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
di: Lucas Antonelli, et al.
Pubblicazione: (2015-01-01)

Association Between Hyperaldosteronemia and Electrophysiological Myocardial Activity in Heart Failure with Preserved Ejection Fraction
di: A. N. Shevelok
Pubblicazione: (2020-10-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
di: Tin‐Kwang Lin, et al.
Pubblicazione: (2019-06-01)

Dietary Interventions in Heart Failure With Preserved Ejection Fraction
di: Hayley E. Billingsley, PhD, RDN, et al.
Pubblicazione: (2025-01-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
di: Sabina Frljak, et al.
Pubblicazione: (2022-03-01)

Contractile Reserve in Heart Failure with Preserved Ejection Fraction
di: Daniela Di Lisi, et al.
Pubblicazione: (2022-08-01)

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
di: Anna L. Beale, et al.
Pubblicazione: (2021-07-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
di: Barry A. Borlaug, MD, et al.
Pubblicazione: (2016-01-01)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
di: Rohan Samson, et al.
Pubblicazione: (2016-01-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
di: Domenico D’Amario, et al.
Pubblicazione: (2019-11-01)

Sex Differences in Heart Failure With Preserved Ejection Fraction
di: Yohei Sotomi, et al.
Pubblicazione: (2021-03-01)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
di: Danielle L. Kirkman, et al.
Pubblicazione: (2020-09-01)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
di: Heng Zeng, et al.
Pubblicazione: (2019-02-01)

Murine Models of Heart Failure With Preserved Ejection Fraction
di: Maria Valero-Muñoz, PhD, et al.
Pubblicazione: (2017-12-01)

Metabolomic fingerprint of heart failure with preserved ejection fraction.
di: Beshay N Zordoky, et al.
Pubblicazione: (2015-01-01)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
di: Shane Nanayakkara, et al.
Pubblicazione: (2018-01-01)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
di: Deepak K. Gupta
Pubblicazione: (2017-02-01)

Prevalence of heart failure preserved ejection fraction in the community
di: Mahadevan, G, et al.
Pubblicazione: (2007)

Principles for diagnosing heart failure with preserved ejection fraction
di: N. E. Shirokov, et al.
Pubblicazione: (2023-09-01)

Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
di: Shunsuke Tamaki, et al.
Pubblicazione: (2013-01-01)

Diagnostic potential of energy metabolism-related genes in heart failure with preserved ejection fraction
di: Qiling Gou, et al.
Pubblicazione: (2023-11-01)

Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction
di: Hui Li, et al.
Pubblicazione: (2022-05-01)

Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction
di: A. N. Shevelok
Pubblicazione: (2021-02-01)

Heart Failure with Preserved Ejection Fraction: Time to Revisit the Stiff Heart
di: Juan R. Vilaro, et al.
Pubblicazione: (2019-01-01)

Impaired myocardial energetics limits cardiac functional reserve and leads to exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
di: Burrage, M, et al.
Pubblicazione: (2021)

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
di: Veronika Zach, et al.
Pubblicazione: (2020-03-01)

Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction
di: Kanako Teramoto, et al.
Pubblicazione: (2022-08-01)